Net Cash Provided by (Used in) Financing Activities of HEALTHEQUITY, INC. from 31 Jan 2013 to 30 Apr 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary: HEALTHEQUITY, INC. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Jan 2013 to 30 Apr 2025.
HEALTHEQUITY, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Apr 2025 was $56,649,000, a 209% decline year-over-year.
HEALTHEQUITY, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $57,567,000.
HEALTHEQUITY, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $47,039,000, a 1661% decline from 2022.
HEALTHEQUITY, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2,671,000, a 101% decline from 2021.
Source SEC data: View on sec.gov

Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)

Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

Net Cash Provided by (Used in) Financing Activities, Annual (USD)

Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

HEALTHEQUITY, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$56,649,000	-$108,420,000	-209%	01 Feb 2025	30 Apr 2025	10-Q	03 Jun 2025	2026	Q1
Q1 2024	$51,771,000	+$102,798,000		01 Feb 2024	30 Apr 2024	10-Q	03 Jun 2025	2026	Q1
Q1 2023	$51,027,000	-$53,986,000	-1824%	01 Feb 2023	30 Apr 2023	10-Q	03 Jun 2024	2025	Q1
Q1 2022	$2,959,000	-$441,894,000	-99%	01 Feb 2022	30 Apr 2022	10-Q	07 Jun 2023	2024	Q1
Q1 2021	$444,853,000	+$455,218,000		01 Feb 2021	30 Apr 2021	10-Q	08 Jun 2022	2023	Q1
Q1 2020	$10,365,000	-$14,594,000	-345%	01 Feb 2020	30 Apr 2020	10-Q	08 Jun 2021	2022	Q1
Q1 2019	$4,229,000	-$5,938,000	-58%	01 Feb 2019	30 Apr 2019	10-Q	04 Jun 2020	2021	Q1
Q1 2018	$10,167,000	+$6,338,000	+166%	01 Feb 2018	30 Apr 2018	10-Q	06 Jun 2019	2020	Q1
Q1 2017	$3,829,000	-$5,594,000	-59%	01 Feb 2017	30 Apr 2017	10-Q	07 Jun 2018	2019	Q1
Q1 2016	$9,423,000	+$4,999,000	+113%	01 Feb 2016	30 Apr 2016	10-Q	08 Jun 2017	2018	Q1
Q1 2015	$4,424,000	+$3,622,000	+452%	01 Feb 2015	30 Apr 2015	10-Q	09 Jun 2016	2017	Q1
Q1 2014	$802,000			01 Feb 2014	30 Apr 2014	10-Q	11 Jun 2015	2016	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$57,567,000	+$104,606,000		01 Feb 2024	31 Jan 2025	10-K	18 Mar 2025	2025	FY
2023	$47,039,000	-$44,368,000	-1661%	01 Feb 2023	31 Jan 2024	10-K	18 Mar 2025	2025	FY
2022	$2,671,000	-$397,534,000	-101%	01 Feb 2022	31 Jan 2023	10-K	18 Mar 2025	2025	FY
2021	$394,863,000	+$342,441,000	+653%	01 Feb 2021	31 Jan 2022	10-K	22 Mar 2024	2024	FY
2020	$52,422,000	-$1,413,313,000	-96%	01 Feb 2020	31 Jan 2021	10-K	30 Mar 2023	2023	FY
2019	$1,465,735,000	+$1,442,806,000	+6292%	01 Feb 2019	31 Jan 2020	10-K	31 Mar 2022	2022	FY
2018	$22,929,000	+$8,365,000	+57%	01 Feb 2018	31 Jan 2019	10-K	31 Mar 2021	2021	FY
2017	$14,564,000	-$9,212,000	-39%	01 Feb 2017	31 Jan 2018	10-K	31 Mar 2020	2020	FY
2016	$23,776,000	-$12,871,000	-35%	01 Feb 2016	31 Jan 2017	10-K	28 Mar 2019	2019	FY
2015	$36,647,000	-$53,832,000	-59%	01 Feb 2015	31 Jan 2016	10-K	28 Mar 2018	2018	FY
2014	$90,479,000	+$95,843,000		01 Feb 2014	31 Jan 2015	10-K	30 Mar 2017	2017	FY
2013	$5,364,000	+$2,094,000	+28%	01 Feb 2013	31 Jan 2014	10-K	31 Mar 2016	2016	FY
2012	$7,458,000			01 Feb 2012	31 Jan 2013	10-K	31 Mar 2015	2015	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.